PCI Synthesis at DCAT Week 2017

Take a Tour of DCAT Week with Ed Price, President and CEO of PCI Synthesis.

Posted: April 6, 2017

API Manufacturing and Pharmaceutical Manufacturing

Related posts:

PCI launches innovative product line: phosphonic acids, used in a wide variety of commercial applica...
PCI Synthesis Announces Another Successful FDA Audit of its Devens, MA Facility
Scott VanderWel Joins PCI Synthesis as Business Development Manager
Purification is a critical step in drug manufacturing
DEA Controlled Substance API manufacturing

About the Author

Ed Price CEO of PCI Synthesis
Ed is the President and CEO of PCI Synthesis (PCI), he serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA).

Do you have questions? Talk to Ed.